Epidemiology of invasive candidiasis in pediatric and adult populations;Epidemiología de las candidiasis invasoras en población pediátrica y adulta

Revista Iberoamericana de Micologia

Volumn 26, Issue 1, 2009, Pages 2-7

  del Palacio, Amalia ^a   Villar, Julia ^a   Alhambra, Almudena ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Candida spp. invasive disease; Candidemia; Critically ill patients; Oncohematologic patients; Pediatric population; Solid organ transplant recipients

Indexed keywords

ADULT; CANCER PATIENT; CANDIDA; CHILD; CRITICAL ILLNESS; HEALTH CARE COST; HEMATOLOGIC MALIGNANCY; HUMAN; INCIDENCE; INVASIVE CANDIDIASIS; MEDLINE; MORBIDITY; MORTALITY; NEWBORN; NONHUMAN; ORGAN TRANSPLANTATION; PEDIATRICS; RECIPIENT; REVIEW;

ADULT; CANDIDIASIS; CHILD; CRITICAL ILLNESS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; INFANT; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; NEOPLASMS; NEUTROPENIA; OPPORTUNISTIC INFECTIONS; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES;

CANDIDA;

EID: 67650751237     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1130-1406(09)70002-6     Document Type: Review

References (70)

1. Abelson J.A., Moore T., Bruckner D., Deville J., and Nielsen K. Frecuency of fungemia in hospitalized pediatric inpatients over 11 year at a tertiary care institution. Pediatrics 116 (2005) 61-67
2. Almirante B., Rodriguez D., Park B.J., Cuenca-Estrella M., Planes A.M., Almela M., Mensa J., Sánchez F., Ayats J., Jiménez M., Saballs P., Fridkin S.K., Morgan J., Rodriguez-Tudela J.L., Warnock D.W., Pahissa A., and The Barcelona Candidemia Project Study Group. Epidemiology and predictors of mortality in cases of Candida bloodstream infections results from population-based surveillance, Barcelona, Spain from 2002 to 2003. J Clin Microbiol 43 (2005) 1829-1835
3. Barnes P.D., and Marr K.A. Risk, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplantation recipients. Br J Haematol 139 (2007) 519-531
4. Benjamin Jr. D.K., Poole C., Steinbach W.J., Rower J.L., and Walsh T.J. Neonatal candidemia and end-organ damage: a critical appraisal of the literature using meta-analytic techniques. Pediatrics 112 (2003) 634-640
5. Bougnoux M.E., Kac G., Aegerter P., D'Enfert C., and Fagon J.Y. Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management and outcome. Intensive Care Med 34 (2008) 292-299
6. Cano M.V., Perz J.F., Craiag A.S., Liu M., Lyon G.M., Brandt M.E., Lott T.J., Lasker B.A., Barrett F.F., Mc Neil M.M., Schaffner W., and Hajjeh R.A. Candidemia in pediatric outpatients receiving home total parenteral nutrition. Med Mycol 43 (2005) 219-225
7. Castagnola E., Caviglia I., Pistorio A., Fioredda F., Micalizzi C., Viscoli C., and Hanpt R. Bloodstream infections and invasive mycoses in children undergoing acute leukaemia treatment: a 13-year experience at a single Italian institution. Eur J Cancer 41 (2005) 1439-1445
8. Castagnola E., Cesaro S., Giacchino M., Livadiotti S., Tucci F., Zanazzo G., Caselli D., Caviglia I., Parodi S., Rondelli R., Cornelli P., Mura R., Santoro N., Russo G., De Santis R., Buffardi S., Viscoli C., Haupt R., Rossi, and Mario R. Fungal infection in children with cancer: a prospective multicenter surveillance study. Pediatr Infect Dis 25 (2006) 634-639
9. Chamilos G., Luna M., Lewis R.E., Bodey G.P., Chemaly R., Tarrand J.J., Safdar A., Raad I.I., and Kontoyannis D.P. Invasive fungal infections in patients with hematologic malignancies in a tertiary care center: an autopsy over a 15 year period (1989-2003). Haematologica 91 (2006) 986-989
10. Chow J.K., Golan I., Ruthazer R., Karchmer A.W., Carmeli Y., Lichtenberg D., Chawila V., Young J., and Hadley S. Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit. Clin Infect Dis 46 (2008) 1206-1213
11. Cuétara M.S., Alhambra A., and Del Palacio A. Diagnóstico microbiológico tradicional de la candidiasis invasora en el enfermo crítico no neutropénico. Rev Iberoam Micol 23 (2006) 4-7
12. Di Nubile M.J., Lupinacci R.J., Strohmaier K.M., Sable C.A., and Kartsonis N.A. Invasive candidiasis treated in the intensive care unit: observations from a randomized clinical trial. J Crit Care 22 (2007) 237-244
13. Dimopoulus G., Ntziora F., Rachiotis G., Armaganadis A., and Falagas M.E. Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome. Anesth Analg 106 (2008) 523-529
14. Eggimann P., Francioli P., Bille J., Schneider R., Wu M.M., Chapuis G., Chiolero R., Pannatier A., Schilling J., Geroulanos S., Glauser M.P., and Calandra T. Fluconazole prophylaxis prevents intra-abdominal candidiasis in high risk surgical patients. Crit Care Med 27 (1999) 1066-1072
15. Filioti J., Spiroglou K., Panteliadis C.P., and Roilides E. Invasive candidiasis in pediatric intensive care patients: epidemiology, risk factors, management and outcome. Intensive Care Med 33 (2007) 1272-1283
16. Forrest G.N., Mankes K., Jabra-Rizk M.A., Weekes E., Jhonson J.K., Lincalis D.P., and Venezia R.A. Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs. J Clin Microbiol 44 (2006) 3381-3383
17. Forrest G.N., Weekes E., and Johnson J.K. Increasing incidence of Candida parapsilosis candidemia with caspofungin usage. J Infect 56 (2008) 126-129
18. Fridkin S.K. Candidemia is costly-plain and simple. Clin Infect Dis 41 (2005) 1240-1241
19. Garey K.W., Rege M., Pai M.P., Mingo D.E., Suda K.J., Turpin R.S., and Bearden D.T. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis 43 (2006) 25-31
20. Gudlaugsson O., Gillispie S., Lee K., Vande Berg J., Hu J., Messer S., Herwaldt L., Pfaller M., and Riekema D. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 37 (2002) 1172-1177
21. Hope W.W., Drusano G.L., Moore C.B., Sharp A., Louie A., Walsh T.J., Denning D.W., and Warn P.A. Effect of neutropenia and treatment delay in the response to antifungal agents in experimental disseminated candidiasis. Antimicrob Agents Chemoter 51 (2007) 285-295
22. Horvath L.L., George B.J., and Hospental D.R. Detection of fifteen species of Candida in an automated blood culture system. J Clin Microbiol 45 (2007) 3062-3064
23. Husain S., Tollemar J., Dominguez E.A., Baumgarten K., Humar A., Paterson D., Wagener M.M., Kusne S., and Singh N. Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controled study. Transplantation 75 (2003) 2023-2029
24. Kibbler C.C., Seaton S., Barnes R.A., Gransden W.R., Holliman R.E., Johnson E.M., Perry J.D., Sullivan D.J., and Wilson J.A. Management and outcome of bloodstream infections due to Candida species in England and Wales. J Hosp Infection 54 (2003) 18-24
25. Knocke M., Bernhardt H., and Schwesinger G. Is there a need for autopsies in the management of fungal disease?. Mycoses 51 (2008) 291-300
26. Krcmery V., and Barnes A.J. Non-albicans Candida spp. causing fungemia: pathogenicity and antifungal resistance. J Hosp Infect 50 (2002) 243-260
27. León C., Ruiz-Santana S., Saavedra P., Almirante B., Nolla Salas J., Alvarez Lerma F., Garnacho-Montero J., and León M.A. A bedside scoring system ("Candida score") for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med 34 (2006) 730-737
28. Levy I., Shalit I., Askenazi S., Klinger G., Sirota L., and Linder N. Duration and outcome of persistent candidaemia in newborn infants. Mycoses 49 (2006) 197-201
29. Lupetti A., Tavanti A., Davini P., Ghelardi E., Corsini V., Merusi I., Boldrini A., Campa M., and Senesi S. Horizontal transmission of Candida parapsilosis candidemia in a neonatal intensive care unit. J Clin Microbiol 40 (2002) 2363-2369
30. Marchetti D., Bille J., Fluckiger U., Eggimann P., Ruef C., Garbino G., Calandra T., Glamer M.P., Tauber M.G., Pittet D., and For the Fungal Infections Network of Switzerland. Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends 1991-2000. Clin Infect Dis 38 (2004) 311-320
31. Marchmeyer G. The changing epidemiology of invasive fungal infections: new threats. Int J Antimicrob Agents 27 Suppl (2006) 53-56
32. Marr K.A., Seidel K., White T.C., and Borden R.A. Candidemia in allogenic blood and marrow transplant recipients: evolution of risk factors after adoption of prophylactic fluconazole. J Infect Dis 181 (2000) 309-316
33. Morrell M., Fraser V.J., and Kollef M.H. Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 49 (2005) 3640-3645
34. Odds F.C. Candidemia and candidosis. Factors that predispose the host to candidosis (1988), Balliere Tindal, London p. 93-114
35. Ostrosky-Zeichner L. New approaches to the risk of Candida in the intensive care unit. Curr Opin Infect Dis 16 (2003) 533-537
36. Ostrosky-Zeichner L., Aranha L., Eggiman P., Garbino J., Herbrecht R., León C., Lortholary O., Pappas P., Sobel J., Sorrel T., Muller E., Treat Study Group, and Houston Tx. Preliminary results of a multicenter, international, retrospective study to validate a clinical prediction rule (CPR) to identify critically-ill patients at a risk of invasive candidiasis (IC) for treatment with empirical antifungal therapy (TREAT study). Washington DC, Interscience Conference on Antimicrobial Agents and Chemotherapy (2008) M-1853 Abstract
37. Ostrosky-Zeichner L., and Pappas P. Invasive candidiasis in the intensive care unit. Crit Care Med 34 (2006) 857-863
38. Ostrosky-Zeichner L., Sable C., Sobel J., Alexander B.D., Donowitz G., Kan V., Kauffman C.A., Kett D., Larsen R.A., Morrison V., Nucci M., Pappas P.G., Bradley M.E., Major S., Zimmer L., Wallace D., Dismukes W.E., and Rex J.H. Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis 26 (2007) 271-276
39. Del Palacio, Alhambra A., and Cuétara M.S. Factores de riesgo de la candidiasis invasora: estratificación. Rev Iberoam Micol 23 (2006) 29-31
40. Del Palacio, Alhambra A., and Cuétara M.S. Estrategias de tratamiento: profilaxis, tratamiento empírico, precoz (anticipado) y dirigido de candidiasis invasora en el enfermo crítico no neutropénico. Rev Iberoam Micol 23 (2006) 35-38
41. Pappas P.G. Invasive candidiasis. Infect Dis Clin N Am 20 (2006) 485-506
42. Pappas P.G., Rex J.H., Lee J., Hamill R.J., Larsen R.A., Powderly W., Kaufman C.A., Hyslop N., Mangino J.E., Chapman S., Horowitz H.W., Edwards J.E., Dismukes W.E., and For the NIAID mycoses study group. A prospective observational study of candidemia: epidemiology, therapy and influences on mortality in hospitalized adult and pediatric patients. Clin Infec Dis 37 (2003) 634-643
43. Parkins M.D., Sobuda D.M., Elsayed S., and Laupland K.B. Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections. J Antimicrob Chemother 60 (2007) 613-618
44. Pfaller M.A., and Diekema D.J. Epidemiology of invasive candidiasis: a persistent public healt problem. Clin Microbiol Rev 20 (2007) 133-163
45. Pitart C., Marco F., Almela M., Muñoz A., Soriano A., Martinez J., Puig J., and Mensa J. Timeto-positivity and blood anaerobic culture vials can predict Candida glabrata bloodstream infections. Washington DC, Interscience Conference on Antimicrobial Agents and Chemotherapy (2008) Abstract M-704
46. Pittet D., and Garbino J. Fungal Infections in the critically ill. Curr Opin Crit Care 1 (1995) 369-380
47. Playford E.G., Marriott D., Nguyen Q., Chen S., Ellis D., Slavin M., and Sorrell T.C. Candidemia in non-neutropenic critically ill patients: risk factors for non-albicans Candida spp. Crit Care Med 36 (2008) 2034-2039
48. Raymond J., and Aujard Y. Nosocomial infections in pediatric patients: a European, multicenter prospective study. European Study Group. Infect Control Hosp Epidemiol 21 (2000) 260-263
49. Reissa E., Lasker B.A., Iqbal N.J., James M.J., and Arthington-Skaggs B.A. Molecular epidemiology of Candida parapsilosis sepsis from outbreak investigations in neonatal intensive care units. Infect Genet Evol 8 (2008) 103-109
50. Rex J.H., and Sobel J.D. Prophylactic antifungal therapy in the intensive care unit. Clin Infect Dis 32 (2001) 1191-1200
51. Rodriguez D., Almirante B., Park B.J., Cuenca-Estrella M., Planes A.M., Sánchez F., Gene A., Xercavins M., Fontanals D., Rodriguez-Tudela J.L., Warnock D.W., and Pahissa A. Candidemia in neonatal intensive care units, Barcelona, Spain. Pediatr Infect Dis J 25 (2006) 224-229
52. Roilides E., Farmaki E., Evdoridou J., Dotis J., Hatziioannidis E., Tsivitanidou M., Bibashi E., Filioti I., Sofianou D., Gil-Lamaignere C., Mueller F.M., and Kremenopoulus G. Neonatal candidiasis: analysis of epidemiology, drug susceptibility and molecular typing of causative isolates. Eur J Clin Microbiol Infect Dis 23 (2004) 745-750
53. Rosen G.P., Nielsen K., Glenn S., Abelson J., Deville J., and Moore T.B. Invasive fungal infections in pediatric oncology patients: 11-year experience at a single institution. J Pediatr Hematol Oncol 27 (2005) 135-140
54. Ruiz I., Rovira M., and Gavalda J. Proven or probable invasive fungal infections (IFI) in hematopoietic stem cell transplant (HSCT) recipients. Interscience conference on Antimicrobial Agents and Chemotherapy. San Francisco CA (2006) Abstract M-888
55. Salavert M. Prophylaxis, pre-emptive or empirical antifungal therapy: which is best in non-lung transplant recipients?. Int J Antimicrob Agents 32 (2008) S149-S153
56. Shorr A.F., Lazarus D.R., Sherner J.H., Jackson W.L., Morrell M., Fraser V.J., and Kollef M.H. Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia. Crit Care Med 35 (2007) 1077-1083
57. Singh N. Antifungal prophylaxis in solid organ transplant recipients: considerations for clinical trial design. Clin Infect Dis 39 (2004) S200-S206
58. Singhi S., Rao R., and Chakrabarti A. Candida colonization and candidemia in a pediatric intensive care unit. Pediatr Crit Care 9 (2008) 91-95
59. Silveira F.P., and Husain S. Fungal infections in solid organ transplantation. Med Mycol 45 (2007) 305-320
60. Smith P.B., Steinbach W.J., and Benjamin Jr. D.K. Neonatal candidiasis. Infect Dis Clin North Am 19 (2005) 603-615
61. Stamos J.K., and Rowley A.H. Candidemia in a pediatric population. Clin Infect Dis 20 (1995) 571-575
62. Takesue Y., Kakehashi M., Ohge H., Imamura Y., Murakami Y., Sasaki M., Morifuji M., Yokoyama Y., Kouyama M., Yokoyama T., and Sueda T. Combined assessment of beta-Dglucan and degree of Candida colonization before starting empiric therapy for candidiasis in surgical patients. World J Surg 28 (2004) 625-630
63. Tortorano A.M., Pemán J., Bernhardt H., Klingspor L., Kibbler C.C., Faure O., Biraghi E., Cantón E., Zimmermann K., Seaton S., Grillot R., and The ECMM working group on candidemia. Epidemiology of candidemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis 23 (2004) 317-322
64. Trick W.E., Fridkin S.K., Edwards J.R., Hajjeh R.A., Gaynes R.P., and The National Nosocomial Infectious Surveillance System Hospitals. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis 35 (2002) 627-630
65. Verma A., Wade J.J., Cheeseman P., Samaroo B., Rela M., Heaton N.D., Mielli-Vergani G., and Dhawn A. Risk factors for fungal infection in pediatric liver transplant recipients. Pediatr Transplant 9 (2005) 220-225
66. De Waele J.J., Vogelaers D., Blot S., and Colardyn F. Fungal infections in patients with severe acute pancreatitis and the use of prophylactic therapy. Clin Infect Dis 37 (2003) 208-213
67. Winston D.J., Pakrasi A., and Bussuttil R.W. Prophylactic fluconazole in liver transplant recipients randomized double-blind, placebo controlled trial. Ann Intern Med 131 (1999) 729-737
68. Wisplinghoff H., Bischoff T., Tallent S.M., Seifert H., Wenzel R.P., and Edmond M.B. Nosocomial bloodstream infection in US hospitals: analysis of 24.179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39 (2004) 309-317
69. Zaoutis T.E., Argon J., Chu J., Berlin J.A., Walsh T.J., and Freudtner C. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis 41 (2005) 1232-1239
70. Zaoutis T., and Walsh T.J. Antifungal therapy for neonatal candidiasis. Curr Opin Infect Dis 20 (2007) 592-597